Industry Research Reports
Global Genetic Disease Testing Market Research Report 2026
Industry: Service & Software
Published Date: 2026-03-11
Pages: 111 Pages
Report ld: 6195547
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Genetic Disease Testing Market Size(US$)
CAGR 2026-2032
11.5%
Market Size,2032
USD 2,267
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 1,178 million
Market Forecast in 2032(Value)
US$ 2,267 million
CAGR
11.5%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Genetic Disease Testing market was valued at US$ 1067 million in 2025 and is anticipated to reach US$ 2267 million by 2032, at a CAGR of 11.5% from 2026 to 2032.
Genetic disease testing, also known as genetic testing, involves analyzing chromosomes, genes, or proteins to identify changes that may lead to genetic disorders. This testing can confirm or rule out suspected genetic conditions or assess the risk of developing or passing on genetic disorders.
Market Development Overview:
In recent years, the genetic disease testing market has seen substantial growth due to advances in genomics, increased awareness of genetic diseases, and growing demand for personalized medicine. The global genetic disease testing market was valued at billions of dollars in 2023 and is expected to expand at a significant compound annual growth rate (CAGR) in the coming years. Factors driving this growth include technological advances in next-generation sequencing (NGS), declining costs of genetic testing, and expanding applications in oncology, rare disease diagnosis, and reproductive health. Governments and healthcare organizations around the world are actively promoting genetic screening programs, further driving market expansion. Direct-to-consumer (DTC) genetic testing is also becoming increasingly popular, with companies offering home testing kits for health risk assessment and ancestry tracing. The market is expected to maintain steady growth as regulators create clearer guidelines for genetic testing services.
Market Development Opportunities:
Next-generation sequencing (NGS) and CRISPR gene editing technologies are revolutionizing genetic testing, enabling faster, more accurate, and more cost-effective diagnoses. The reduction in the cost of whole genome sequencing makes genetic testing more accessible to a wider range of people. As healthcare shifts toward personalized treatment plans, genetic testing is becoming an important tool to tailor treatments to patients’ genetic profiles. Precision oncology in particular benefits from genetic insights that enable targeted cancer treatments. Many rare genetic diseases remain undiagnosed due to the complexity of traditional diagnostic methods. Advances in genetic testing are improving early detection and management of these diseases, creating new market opportunities. With consumers’ growing interest in health and ancestry, demand for direct-to-consumer genetic testing companies has surged. Companies are also developing AI-driven analytics to provide more personalized insights from genetic data.
Market Risks and Challenges:
Genetic testing raises ethical questions about data privacy, consent, and potential misuse of genetic information. Governments are implementing stricter regulations, which could impact market growth if compliance costs increase. As genetic testing companies collect large amounts of sensitive personal data, the risk of data breaches and misuse continues to increase. Ensuring secure storage and ethical use of genetic data is a key concern for industry stakeholders. Despite declining sequencing costs, genetic testing remains expensive in many regions, limiting accessibility to low-income populations. Insurance coverage for genetic testing also varies, impacting adoption rates. Without appropriate genetic counseling, consumers and patients may misinterpret test results, leading to unnecessary anxiety or inappropriate medical decisions. Expanding access to genetic counseling services is critical to mitigating this risk.
This report delivers a comprehensive overview of the global Genetic Disease Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Genetic Disease Testing. The Genetic Disease Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Genetic Disease Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Genetic Disease Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Invitae
- Ambry Genetics
- Exact Sciences
- Qiagen
- Tempus
- 23andme
- Veritas Genetics
- Myriad Genetics
- LabCorp
- Blueprint Genetics
- Illumina
- CENTOGENE
- GeneDx
- Fulgent Genetics
- BGI Genomics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Direct Genetic Testing
- Indirect Genetic Testing
Segment by Application
- Carrier Testing
- Prenatal Testing
- Newborn Screening
- Others
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Genetic Disease Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Disease Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Direct Genetic Testing
1.2.3 Indirect Genetic Testing
1.3 Market by Application
1.3.1 Global Genetic Disease Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Carrier Testing
1.3.3 Prenatal Testing
1.3.4 Newborn Screening
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Disease Testing Market Perspective (2021–2032)
2.2 Global Genetic Disease Testing Growth Trends by Region
2.2.1 Global Genetic Disease Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Genetic Disease Testing Historic Market Size by Region (2021–2026)
2.2.3 Genetic Disease Testing Forecasted Market Size by Region (2027–2032)
2.3 Genetic Disease Testing Market Dynamics
2.3.1 Genetic Disease Testing Industry Trends
2.3.2 Genetic Disease Testing Market Drivers
2.3.3 Genetic Disease Testing Market Challenges
2.3.4 Genetic Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Disease Testing Players by Revenue
3.1.1 Global Top Genetic Disease Testing Players by Revenue (2021–2026)
3.1.2 Global Genetic Disease Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Genetic Disease Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Genetic Disease Testing Revenue
3.4 Global Genetic Disease Testing Market Concentration Ratio
3.4.1 Global Genetic Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Disease Testing Revenue in 2025
3.5 Global Key Players of Genetic Disease Testing Head Offices and Areas Served
3.6 Global Key Players of Genetic Disease Testing, Products and Applications
3.7 Global Key Players of Genetic Disease Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Genetic Disease Testing Breakdown Data by Type
4.1 Global Genetic Disease Testing Historic Market Size by Type (2021–2026)
4.2 Global Genetic Disease Testing Forecasted Market Size by Type (2027–2032)
5 Genetic Disease Testing Breakdown Data by Application
5.1 Global Genetic Disease Testing Historic Market Size by Application (2021–2026)
5.2 Global Genetic Disease Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Genetic Disease Testing Market Size (2021–2032)
6.2 North America Genetic Disease Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Genetic Disease Testing Market Size by Country (2021–2026)
6.4 North America Genetic Disease Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetic Disease Testing Market Size (2021–2032)
7.2 Europe Genetic Disease Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Genetic Disease Testing Market Size by Country (2021–2026)
7.4 Europe Genetic Disease Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Genetic Disease Testing Market Size (2021–2032)
8.2 Asia-Pacific Genetic Disease Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Genetic Disease Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Genetic Disease Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Genetic Disease Testing Market Size (2021–2032)
9.2 Latin America Genetic Disease Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Genetic Disease Testing Market Size by Country (2021–2026)
9.4 Latin America Genetic Disease Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Disease Testing Market Size (2021–2032)
10.2 Middle East & Africa Genetic Disease Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Genetic Disease Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Genetic Disease Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Invitae
11.1.1 Invitae Company Details
11.1.2 Invitae Business Overview
11.1.3 Invitae Genetic Disease Testing Introduction
11.1.4 Invitae Revenue in Genetic Disease Testing Business (2021–2026)
11.1.5 Invitae Recent Development
11.2 Ambry Genetics
11.2.1 Ambry Genetics Company Details
11.2.2 Ambry Genetics Business Overview
11.2.3 Ambry Genetics Genetic Disease Testing Introduction
11.2.4 Ambry Genetics Revenue in Genetic Disease Testing Business (2021–2026)
11.2.5 Ambry Genetics Recent Development
11.3 Exact Sciences
11.3.1 Exact Sciences Company Details
11.3.2 Exact Sciences Business Overview
11.3.3 Exact Sciences Genetic Disease Testing Introduction
11.3.4 Exact Sciences Revenue in Genetic Disease Testing Business (2021–2026)
11.3.5 Exact Sciences Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Genetic Disease Testing Introduction
11.4.4 Qiagen Revenue in Genetic Disease Testing Business (2021–2026)
11.4.5 Qiagen Recent Development
11.5 Tempus
11.5.1 Tempus Company Details
11.5.2 Tempus Business Overview
11.5.3 Tempus Genetic Disease Testing Introduction
11.5.4 Tempus Revenue in Genetic Disease Testing Business (2021–2026)
11.5.5 Tempus Recent Development
11.6 23andme
11.6.1 23andme Company Details
11.6.2 23andme Business Overview
11.6.3 23andme Genetic Disease Testing Introduction
11.6.4 23andme Revenue in Genetic Disease Testing Business (2021–2026)
11.6.5 23andme Recent Development
11.7 Veritas Genetics
11.7.1 Veritas Genetics Company Details
11.7.2 Veritas Genetics Business Overview
11.7.3 Veritas Genetics Genetic Disease Testing Introduction
11.7.4 Veritas Genetics Revenue in Genetic Disease Testing Business (2021–2026)
11.7.5 Veritas Genetics Recent Development
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Details
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Genetic Disease Testing Introduction
11.8.4 Myriad Genetics Revenue in Genetic Disease Testing Business (2021–2026)
11.8.5 Myriad Genetics Recent Development
11.9 LabCorp
11.9.1 LabCorp Company Details
11.9.2 LabCorp Business Overview
11.9.3 LabCorp Genetic Disease Testing Introduction
11.9.4 LabCorp Revenue in Genetic Disease Testing Business (2021–2026)
11.9.5 LabCorp Recent Development
11.10 Blueprint Genetics
11.10.1 Blueprint Genetics Company Details
11.10.2 Blueprint Genetics Business Overview
11.10.3 Blueprint Genetics Genetic Disease Testing Introduction
11.10.4 Blueprint Genetics Revenue in Genetic Disease Testing Business (2021–2026)
11.10.5 Blueprint Genetics Recent Development
11.11 Illumina
11.11.1 Illumina Company Details
11.11.2 Illumina Business Overview
11.11.3 Illumina Genetic Disease Testing Introduction
11.11.4 Illumina Revenue in Genetic Disease Testing Business (2021–2026)
11.11.5 Illumina Recent Development
11.12 CENTOGENE
11.12.1 CENTOGENE Company Details
11.12.2 CENTOGENE Business Overview
11.12.3 CENTOGENE Genetic Disease Testing Introduction
11.12.4 CENTOGENE Revenue in Genetic Disease Testing Business (2021–2026)
11.12.5 CENTOGENE Recent Development
11.13 GeneDx
11.13.1 GeneDx Company Details
11.13.2 GeneDx Business Overview
11.13.3 GeneDx Genetic Disease Testing Introduction
11.13.4 GeneDx Revenue in Genetic Disease Testing Business (2021–2026)
11.13.5 GeneDx Recent Development
11.14 Fulgent Genetics
11.14.1 Fulgent Genetics Company Details
11.14.2 Fulgent Genetics Business Overview
11.14.3 Fulgent Genetics Genetic Disease Testing Introduction
11.14.4 Fulgent Genetics Revenue in Genetic Disease Testing Business (2021–2026)
11.14.5 Fulgent Genetics Recent Development
11.15 BGI Genomics
11.15.1 BGI Genomics Company Details
11.15.2 BGI Genomics Business Overview
11.15.3 BGI Genomics Genetic Disease Testing Introduction
11.15.4 BGI Genomics Revenue in Genetic Disease Testing Business (2021–2026)
11.15.5 BGI Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Genetic Disease Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Direct Genetic Testing
Table 3. Key Players of Indirect Genetic Testing
Table 4. Global Genetic Disease Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Genetic Disease Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Genetic Disease Testing Market Size by Region (US$ Million), 2021–2026
Table 7. Global Genetic Disease Testing Market Share by Region (2021–2026)
Table 8. Global Genetic Disease Testing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Genetic Disease Testing Market Share by Region (2027–2032)
Table 10. Genetic Disease Testing Market Trends
Table 11. Genetic Disease Testing Market Drivers
Table 12. Genetic Disease Testing Market Challenges
Table 13. Genetic Disease Testing Market Restraints
Table 14. Global Genetic Disease Testing Revenue by Players (US$ Million), 2021–2026
Table 15. Global Genetic Disease Testing Market Share by Players (2021–2026)
Table 16. Global Top Genetic Disease Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Genetic Disease Testing Revenue, 2025
Table 17. Ranking of Global Top Genetic Disease Testing Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Genetic Disease Testing Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Genetic Disease Testing, Headquarters and Area Served
Table 20. Global Key Players of Genetic Disease Testing, Products and Applications
Table 21. Global Key Players of Genetic Disease Testing, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Genetic Disease Testing Market Size by Type (US$ Million), 2021–2026
Table 24. Global Genetic Disease Testing Revenue Market Share by Type (2021–2026)
Table 25. Global Genetic Disease Testing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Genetic Disease Testing Revenue Market Share by Type (2027–2032)
Table 27. Global Genetic Disease Testing Market Size by Application (US$ Million), 2021–2026
Table 28. Global Genetic Disease Testing Revenue Market Share by Application (2021–2026)
Table 29. Global Genetic Disease Testing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Genetic Disease Testing Revenue Market Share by Application (2027–2032)
Table 31. North America Genetic Disease Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Genetic Disease Testing Market Size by Country (US$ Million), 2021–2026
Table 33. North America Genetic Disease Testing Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Genetic Disease Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Genetic Disease Testing Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Genetic Disease Testing Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Genetic Disease Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Genetic Disease Testing Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Genetic Disease Testing Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Genetic Disease Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Genetic Disease Testing Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Genetic Disease Testing Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Genetic Disease Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Genetic Disease Testing Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Genetic Disease Testing Market Size by Country (US$ Million), 2027–2032
Table 46. Invitae Company Details
Table 47. Invitae Business Overview
Table 48. Invitae Genetic Disease Testing Product
Table 49. Invitae Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 50. Invitae Recent Development
Table 51. Ambry Genetics Company Details
Table 52. Ambry Genetics Business Overview
Table 53. Ambry Genetics Genetic Disease Testing Product
Table 54. Ambry Genetics Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 55. Ambry Genetics Recent Development
Table 56. Exact Sciences Company Details
Table 57. Exact Sciences Business Overview
Table 58. Exact Sciences Genetic Disease Testing Product
Table 59. Exact Sciences Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 60. Exact Sciences Recent Development
Table 61. Qiagen Company Details
Table 62. Qiagen Business Overview
Table 63. Qiagen Genetic Disease Testing Product
Table 64. Qiagen Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 65. Qiagen Recent Development
Table 66. Tempus Company Details
Table 67. Tempus Business Overview
Table 68. Tempus Genetic Disease Testing Product
Table 69. Tempus Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 70. Tempus Recent Development
Table 71. 23andme Company Details
Table 72. 23andme Business Overview
Table 73. 23andme Genetic Disease Testing Product
Table 74. 23andme Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 75. 23andme Recent Development
Table 76. Veritas Genetics Company Details
Table 77. Veritas Genetics Business Overview
Table 78. Veritas Genetics Genetic Disease Testing Product
Table 79. Veritas Genetics Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 80. Veritas Genetics Recent Development
Table 81. Myriad Genetics Company Details
Table 82. Myriad Genetics Business Overview
Table 83. Myriad Genetics Genetic Disease Testing Product
Table 84. Myriad Genetics Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 85. Myriad Genetics Recent Development
Table 86. LabCorp Company Details
Table 87. LabCorp Business Overview
Table 88. LabCorp Genetic Disease Testing Product
Table 89. LabCorp Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 90. LabCorp Recent Development
Table 91. Blueprint Genetics Company Details
Table 92. Blueprint Genetics Business Overview
Table 93. Blueprint Genetics Genetic Disease Testing Product
Table 94. Blueprint Genetics Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 95. Blueprint Genetics Recent Development
Table 96. Illumina Company Details
Table 97. Illumina Business Overview
Table 98. Illumina Genetic Disease Testing Product
Table 99. Illumina Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 100. Illumina Recent Development
Table 101. CENTOGENE Company Details
Table 102. CENTOGENE Business Overview
Table 103. CENTOGENE Genetic Disease Testing Product
Table 104. CENTOGENE Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 105. CENTOGENE Recent Development
Table 106. GeneDx Company Details
Table 107. GeneDx Business Overview
Table 108. GeneDx Genetic Disease Testing Product
Table 109. GeneDx Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 110. GeneDx Recent Development
Table 111. Fulgent Genetics Company Details
Table 112. Fulgent Genetics Business Overview
Table 113. Fulgent Genetics Genetic Disease Testing Product
Table 114. Fulgent Genetics Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 115. Fulgent Genetics Recent Development
Table 116. BGI Genomics Company Details
Table 117. BGI Genomics Business Overview
Table 118. BGI Genomics Genetic Disease Testing Product
Table 119. BGI Genomics Revenue in Genetic Disease Testing Business (US$ Million), 2021–2026
Table 120. BGI Genomics Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Genetic Disease Testing Picture
Figure 2. Global Genetic Disease Testing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Genetic Disease Testing Market Share by Type: 2025 vs 2032
Figure 4. Direct Genetic Testing Features
Figure 5. Indirect Genetic Testing Features
Figure 6. Global Genetic Disease Testing Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Genetic Disease Testing Market Share by Application: 2025 vs 2032
Figure 8. Carrier Testing Case Studies
Figure 9. Prenatal Testing Case Studies
Figure 10. Newborn Screening Case Studies
Figure 11. Others Case Studies
Figure 12. Genetic Disease Testing Report Years Considered
Figure 13. Global Genetic Disease Testing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Genetic Disease Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Genetic Disease Testing Market Share by Region: 2025 vs 2032
Figure 16. Global Genetic Disease Testing Market Share by Players in 2025
Figure 17. Global Genetic Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Genetic Disease Testing Revenue in 2025
Figure 19. North America Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Genetic Disease Testing Market Share by Country (2021–2032)
Figure 21. United States Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Genetic Disease Testing Market Share by Country (2021–2032)
Figure 25. Germany Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Genetic Disease Testing Market Share by Region (2021–2032)
Figure 33. China Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Genetic Disease Testing Market Share by Country (2021–2032)
Figure 41. Mexico Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Genetic Disease Testing Market Share by Country (2021–2032)
Figure 45. Israel Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Genetic Disease Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Invitae Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 49. Ambry Genetics Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 50. Exact Sciences Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 51. Qiagen Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 52. Tempus Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 53. 23andme Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 54. Veritas Genetics Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 55. Myriad Genetics Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 56. LabCorp Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 57. Blueprint Genetics Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 58. Illumina Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 59. CENTOGENE Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 60. GeneDx Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 61. Fulgent Genetics Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 62. BGI Genomics Revenue Growth Rate in Genetic Disease Testing Business (2021–2026)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 11.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Genetic Disease Testing in 2026?
Which companies rank high in the global Genetic Disease Testing market?
What was the global market size of Genetic Disease Testing in 2032?
What is the annual compound growth rate of the global Genetic Disease Testing market size from 2026 to 2032?
Related Reports
Global Genetic Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2267 million by 2032, at a CAGR of 11.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 145
USD 4900.00
(Single User License)
Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Genetic Disease Testing market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 2267 million by 2032 with a CAGR of 11.5% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 94
USD 4250.00
(Single User License)
Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Genetic Disease Testing was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 2267 million, growing at a CAGR of 11.5% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 106
USD 3950.00
(Single User License)
Global Genetic Disease Testing Market Insights, Forecast to 2031
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2054 million by 2031, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period.
Published Date: 2025-03-28
Pages: 132
USD 4900.00
(Single User License)
Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Genetic Disease Testing market size was US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 95
USD 4250.00
(Single User License)
Global Genetic Disease Testing Market Research Report 2025
The global market for Genetic Disease Testing was valued at US$ 1026 million in the year 2024 and is projected to reach a revised size of US$ 2054 million by 2031, growing at a CAGR of 11.5% during the forecast period.
Published Date: 2025-03-28
Pages: 87
USD 2900.00
(Single User License)
Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Genetic Disease Testing was estimated to be worth US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 101
USD 3950.00
(Single User License)
Global Genetic Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2267 million by 2032, at a CAGR of 11.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 145
USD 4900.00 (Single User License)Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Genetic Disease Testing market size was US$ 1067 million in 2025 and is forecast to reach a readjusted size of US$ 2267 million by 2032 with a CAGR of 11.5% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 94
USD 4250.00 (Single User License)Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Genetic Disease Testing was estimated to be worth US$ 1067 million in 2025 and is projected to reach US$ 2267 million, growing at a CAGR of 11.5% from 2026 to 2032.
Published: 2026-03-09
Pages: 106
USD 3950.00 (Single User License)Global Genetic Disease Testing Market Insights, Forecast to 2031
The global Genetic Disease Testing market is projected to grow from US$ 1067 million in 2025 to US$ 2054 million by 2031, at a Compound Annual Growth Rate (CAGR) of 11.5% during the forecast period.
Published: 2025-03-28
Pages: 132
USD 4900.00 (Single User License)Global Genetic Disease Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Genetic Disease Testing market size was US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 95
USD 4250.00 (Single User License)Global Genetic Disease Testing Market Research Report 2025
The global market for Genetic Disease Testing was valued at US$ 1026 million in the year 2024 and is projected to reach a revised size of US$ 2054 million by 2031, growing at a CAGR of 11.5% during the forecast period.
Published: 2025-03-28
Pages: 87
USD 2900.00 (Single User License)Genetic Disease Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Genetic Disease Testing was estimated to be worth US$ 1026 million in 2024 and is forecast to a readjusted size of US$ 2054 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 101
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now